Filing Details

Accession Number:
0001209191-12-025739
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-03 16:21:10
Reporting Period:
2012-05-01
Filing Date:
2012-05-03
Accepted Time:
2012-05-03 16:21:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012140 Onyx Pharmaceuticals Inc ONXX Biological Products, (No Disgnostic Substances) (2836) 943154463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235945 Wendall Wierenga C/O Onyx Pharmaceuticals, Inc.
249 East Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-05-01 250 $45.47 8,330 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.